title: Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
abstract: We recently found that the type IV-specific phosphodiesterase inhibitor Ro 20-1724 increases isoproterenol-induced cAMP secretion in the isolated rat kidney, whereas type I- and type III-specific phosphodiesterase inhibitors do not. Because cAMP is a known vasodilator of renal microvessels, we examined whether Ro 20-1724 is protective against endotoxin-induced acute renal failure. Fifteen rats were anesthetized, instrumented and administered a constant rate intravenous infusion of either Ro 20-1724 (10 micrograms/kg/min; n = 6) or vehicle (n = 9). After 1 hr, a base-line renal clearance period was conducted. All rats then received intravenous endotoxin (20 mg/kg), and six additional renal clearance periods were performed. Urinary cAMP excretion in the Ro 20-1724 group was elevated 2- to 3-fold (P < .01) compared with the control group throughout the protocol. In the control group, endotoxin decreased renal blood flow, increased renal vascular resistance and decreased glomerular filtration rate. Ro 20-1724 markedly attenuated endotoxin-induced changes in renal blood flow (P = .0004), renal vascular resistance (P = .0001) and glomerular filtration rate (P < .0001). The type IV-specific phosphodiesterase inhibitors warrant further study as selective therapeutic agents in the treatment of endotoxin-induced renal failure.
authors.affiliation: Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: D P
authors.initials: DP
authors.lastname: Begany
authors.forename: J A
authors.initials: JA
authors.lastname: Carcillo
authors.forename: W A
authors.initials: WA
authors.lastname: Herzer
authors.forename: Z
authors.initials: Z
authors.lastname: Mi
authors.forename: E K
authors.initials: EK
authors.lastname: Jackson
mesh_terms: D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology*; D058186:Acute Kidney Injury / Q000139:chemically induced*; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D004731:Endotoxins / Q000494:pharmacology*; D008297:Male; D010727:Phosphoric Diester Hydrolases / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004731:Endotoxins; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D010727:Phosphoric Diester Hydrolases